Immunotherapeutics | EUSTM-2022 (From Biology to Patients Care) on October
Topics:
Antivirals
Biomarkers Development
Biomedical Research
Biotech Research
Cell Therapies
Cheminformatics/Bioinformatics
Clinical Trials
DNA-encoded Libraries
Drug Discovery and Development
Epigenetics Research
Gene editing
Genetic Engineering
Healthcare Technologies
Medicinal Chemistry
Microbiome Research
Nanomedicine
Omics Research
Pharma 4.0 (Digital Tech and Data Analytics)
Pharmacogenomics and Personalized Medicine
Pharmacology and Toxicology
Pharmacovigilance
RNA-focused Drug Discovery
Research Equipment and Tools
Stem-Cell Research/Therapy
Translational Research
Congress will focus on recent advances in the field of immunotherapeutics for solid tumors, hematological malignancies, autoimmune disorders, infectious disease, Covid, & vaccines covering from biological research, diagnostics & biomarkers to clinical care.
EUSTM-2022 not only provides a unique platform for scientific exchange and discussion about the recent progress in both bench and bed side of immunotherapies for cancer and infectious diseases, but also an avenue for global networking with key stakeholders in academic research, clinical care giver, public health workers, and industrial leaders.